別品名 |
Imodium, Tebloc, Dissenten, Lopemin, 4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α- diphenyl-1-piperidinbutanamide hydrochloride
|
別包装 |
あり
|
純度 |
>=98%
|
分子量 |
513.51
|
CAS RN® |
34552-83-5
|
化合物の概要 |
FIASMA, μOR agonist, potential HCN channel blocker.
|
構造 |
C29H33ClN2O2 HCl
|
溶媒 |
Soluble in methanol or chloroform.
|
使用目的 |
Loperamide is a μ-opioid receptor (μOR) agonist that exhibits gastrointestinal motility modulating, anorexigenic, analgesic, and antinociceptive activities; it also potentially inhibits HCN channels. Loperamide is clinically used as an anti-diarrheal drug as it increases gastric emptying and decreases bowel water content. Loperamide also alters pain thresholds in animal models as measured by the Hargreaves paw withdrawal apparatus. Additionally, loperamide decreases foraging behavior and body weight in vivo. Loperamide also acts as a functional inhibitor of acid sphingomyelinase (FIASMA).
|
その他 |
[融点]222℃-223℃
|
参考文献 |
Kumar R. Loperamide: from antidiarrheal to analgesic. J Opioid Manag. 2013 Jul-Aug;9(4):301-2. PMID: 24353024.Kumar R, Reeta KH, Ray SB. Antinociceptive effect of intrathecal loperamide: role of mu-opioid receptor and calcium channels. Eur J Pharmacol. 2012 Dec 5;696(1-3):77-82. PMID: 23022331.Placidi E, Marciani L, Hoad CL, et al. The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea. Aliment Pharmacol Ther. 2012 Jul;36(1):64-73. PMID: 22582872.Chumakova YA, Bashkatova VG, Sudakov SK. Changes in feeding behavior after peripheral loperamide administration in rats. Bull Exp Biol Med. 2011 Feb;150(4):398-400. PMID: 22268026.
|
※サムネイル画像をクリックすると拡大画像が表示されます。
|
|
|
メーカー |
品番 |
包装 |
LKT
|
L5660
|
25 G
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
1週間程度
|
保存温度 |
常温
|
|